BLC's 67 performance hits record high, raking in 1,557 million baht in revenue, driven by growth in generic and new generic drugs

“BLC” 67 performance hits record high, raking in 1,557 million baht in revenue, driven by growth in generic and new generic drugs, aiming for 68 to expand herbal products, cosmetics, and pet products

On February 25, 2025, Mr. Suwit Ngamphuphan, Chief Executive Officer of Bangkok Lab & Cosmetic Public Company Limited (BLC), a manufacturer and distributor of modern medicines, including generic and new generic drugs, herbal products, veterinary drugs, and a comprehensive range of health products covering dietary supplements, cosmetics, and other products, disclosed the operating results for the fourth quarter (October – December) of 2024.

The Company has been able to perform outstandingly, with continuous record high operating results, with sales and service revenue of 423 million baht and net profit of 54.8 million baht, growing by 7.0% and 9.4% YoY.

The key driving factors were the distribution of generic and new generic drugs to hospitals and pharmacies, and the collaboration with leading Japanese pharmaceutical companies such as Nishiiko (Thailand) Co., Ltd. to expand drug distribution into pharmacies. The success of the Clena Ex product, which was initially marketed through influencers, also contributed to this growth. As a result, total revenue in 2567 reached 1,557 million baht, a 10.7% increase year-on-year (YoY), while net profit reached 176.1 million baht, a 16.8% increase year-on-year (YoY).

By focusing on the distribution of products with high profit margins and effective cost management, the net profit margin increased from 10.7% to 11.3%. The product groups with outstanding growth are still generic drugs and new generic drugs. In addition, herbal products also have a high growth trend compared to the previous year.

In return for the dividend payment, the Board of Directors, at its meeting on February 24, 2568, approved the payment of a dividend for the 2567 fiscal year at a rate of 0.09 baht per share. The record date for shareholders entitled to receive the dividend will be April 11, 2568, and the payment date will be April 30, 2568.

Furthermore , for 2568, the company maintains its target of average annual growth of 200 million baht, focusing on driving growth through the company's core strategies for 2568, which include:

1.) Proactive marketing through creating Brand Awareness with the strategy of using presenters to reach the target group more and advertising on online platforms, TVC and integrated marketing communications.

2.) Expand online distribution channels, focusing on increasing consumer access via e-Commerce platforms in non-drug product groups such as cosmetics, herbal products, and dietary supplements.

3.) Continuously develop and launch new products, focusing on expanding herbal products that have high growth potential, including expanding into the pet industry to support the increasing demand from the Pet Humanization trend, such as pet supplements (cat licks), as well as developing new health products such as Deeday brand supplements and cosmetics, etc.

4.) Expanding foreign markets by focusing on expanding markets in existing countries where the company has business partners and understands the needs of customer groups through the continuous addition of new product lines.

With a strong strategy and continuous market expansion, the company will grow according to its goals.

However, to support future growth in line with business expansion plans, BLC is moving forward with the construction of a new pharmaceutical manufacturing building as planned, along with investing in a second solar farm to use clean energy, reduce dependence on external electricity, and help reduce the organization’s greenhouse gas emissions. In addition, the company plans to increase production capacity by installing new machinery with advanced technology to support the growth of current pharmaceutical and health products.

In addition, the company has developed an automated system in the production process to reduce costs and increase operational efficiency, which will help the company to efficiently respond to increasing market demands.

Read all interesting business news here.